治疗IgA病症:是时候改变范式了
Jonathan Barratt1, Richard A Lafayette2, Jürgen Floege3
1Department of Cardiovascular Sciences, University of Leicester and Leicester General Hospital, Leicester, United Kingdom.
Frontiers in medicine
|August 30, 2024
概括
免疫球蛋白A脏病 (IgAN) 治疗旨在通过解决其慢性脏病和免疫学方面来预防功能衰竭. 组合疗法正在成为阻止IGAN进展的有希望的策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫球蛋白A脏病 (IgAN) 是慢性病和衰竭的主要原因.
- 目前的治疗模式侧重于减缓疾病进展和保持功能.
研究的目的:
- 审查目前Igan的治疗环境.
- 探索IGAN的新兴治疗策略和组合治疗方法.
- 强调早期干预和全面治疗计划的必要性.
主要方法:
- 对IGAN最近批准的和正在研究的治疗方法的审查.
- 讨论组合治疗方法.
- 分析正在进行的临床试验和未来的研究方向.
主要成果:
- 已获批准的治疗方法包括布德森尼德和斯帕森坦.
- 调查药物向的途径包括内甲林,APRIL/BAFF和补充剂.
- 结合疗法,如SGLT2抑制剂与内甲素受体对抗剂,正在研究中.
结论:
- 作为慢性脏疾病和免疫疾病,Igan需要治疗.
- 组合疗法在阻止IgAN进展和预防功能衰竭方面具有显著的前景.
- 进一步的研究和临床试验对于建立最佳组合治疗策略至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
408
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
408
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Antihypertensive Drugs: Direct Renin Inhibitors
511
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511
Chronic Pancreatitis II: Collaborative Care
77
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
77
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145


